Recombinant Vaccines Market Poised to Register at CAGR of 6.1% by 2028: GlaxoSmithKline Biologicals, MERCK & CO., INC, Dynavax Technologies Corporation
The study on the recombinant vaccines market was recently published by the company, which provides comprehensive information about the most important market dynamics that prove instrumental in the growth of the recombinant vaccines market during 2018-2028.
View full press release